447.95
+25.75
+(6.10%)
As of 5:25:18 PM GMT+1. Market Open.
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
VX1.HM | -- | -- | -- | -- |
S&P 500 | -- | -- | -- | -- |
Upgrades & Downgrades
Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/31/2025 |
Maintains | Scotiabank: Sector Perform to Sector Perform | 1/31/2025 |
Maintains | HC Wainwright & Co.: Buy to Buy | 1/31/2025 |
Reiterates | Needham: Hold to Hold | 1/31/2025 |
Downgrade | Wells Fargo: Overweight to Equal-Weight | 1/30/2025 |
Maintains | Piper Sandler: Overweight to Overweight | 1/27/2025 |
Related Tickers
2H51.HM Ocugen Inc
0.7185
+1.27%
T9G.SG Vidac Pharma Holding Plc
0.6350
-3.79%
2H51.MU Ocugen Inc
0.7490
+7.00%
NP5.DE Newron Pharmaceuticals S.p.A.
10.18
+3.14%
1VT.F Viking Therapeutics, Inc.
32.03
-0.22%
ROVI.MC Laboratorios Farmaceuticos Rovi, S.A.
65.55
+0.08%
ADIL Adial Pharmaceuticals, Inc.
0.8050
-3.01%
DAWN Day One Biopharmaceuticals, Inc.
12.40
-3.58%
VINC Vincerx Pharma, Inc.
1.5200
+1.33%
BNTX BioNTech SE
122.10
+1.01%